Insurance: health insurers; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406zz.
Impact
If enacted, SB0718 would significantly impact state laws governing health insurance, particularly in relation to women's health issues. The bill emphasizes the inclusion of menopause and perimenopause treatments within standard health insurance coverage, thereby addressing a critical area of women's healthcare that has often been neglected. By eliminating requirements for prior authorization or fail-first policies, the bill aims to simplify access to necessary treatments for women, potentially improving health outcomes and quality of life during significant transitional phases in their lives.
Summary
Senate Bill 718, also known as SB0718, seeks to amend the insurance code of 1956 in Michigan by adding section 3406zz. The bill mandates that health insurers providing coverage in the state must cover medically necessary care or treatment related to menopause and perimenopause. This includes treatments such as hormone replacement therapy that are approved by the FDA. Additionally, the bill prohibits insurers from requiring prior authorization for these treatments, as well as prohibiting policies that would necessitate a fail-first approach before receiving coverage for prescribed medications related to menopause and perimenopause.
Contention
While the bill is poised to enhance access to important healthcare treatments, there may be concerns regarding administrative costs for insurers and the implications of mandating such coverage. Opponents might argue that removing prior authorization requirements could lead to increased healthcare costs overall and unintended consequences for insurers who may struggle to manage the financial impacts. However, proponents advocate that the benefits of improved access to care for women experiencing menopause and perimenopause symptoms far outweigh potential drawbacks.
Insurance: health insurers; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406zz.
Human services: medical services; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require. Amends sec. 109h of 1939 PA 280 (MCL 400.109h) & adds sec. 109t.
Human services: medical services; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require. Amends sec. 109h of 1939 PA 280 (MCL 400.109h) & adds sec. 109t.